6 min read
New drug for Leukemia(AML): Bristol-Myers Squibb Onureg (Azacitidine Tablets) was approved by EU Leukemia (AML): Bristol-Myers Squibb Onureg was approved...
Drugs
6 min read
12 min read
Clinical application of interleukin in tumor immunotherapy Clinical application of interleukin in tumor immunotherapy. Interleukins and related cytokines...
16 min read
The main points and challenges of ADC drug PK/PD research The main points and challenges of ADC drug...
4 min read
First precision treatment for systemic mastocytosis (SM): Ayvakit (Avatinib)! The U.S. FDA approved the KIT inhibitor Ayvakit (Avatinib) First...
3 min read
The latest research progress of protein degradation agents: 29 effective individuals and 7 future opportunities Protein degradation agents:...
9 min read
Important 10 questions about Large-scale production of viral vectors Important 10 questions about Large-scale production of viral vectors. ...
10 min read
How to optimize the production of Plasmid DNA for cell and gene therapy? How to optimize the production...
8 min read
How T-DXd becomes a game changer in HER-2+ solid tumor treatment? How T-DXd becomes a game changer in...
4 min read
The world's first red blood cell maturation agent: Bristol-Myers Reblozyl The world's first red blood cell maturation agent:...
4 min read
IL-30: A cytokine that promotes cancer development IL-30: A cytokine that promotes cancer development. IL-30 was discovered in 2002,...
4 min read
Depression (MDD): Zuranolone quickly relieves symptoms after 2 weeks Depression (MDD): Zuranolone quickly relieves symptoms after 2 weeks. New medicine...
11 min read
Tisagenlecleucel to treat adult relapsed or refractory diffuse large B-cell lymphoma Tisagenlecleucel to treat relapsed or refractory diffuse...
2 min read
First-line treatment of advanced nasopharyngeal cancer by immunotherapy First-line treatment of advanced nasopharyngeal cancer by immunotherapy. A study...
10 min read
Why did FDA approve Aducanumab for AD even most experts objected? Why did FDA approve Aducanumab for AD even...
6 min read
Application and Prospect of Allosteric Design in Protein Engineering Application and Prospect of Allosteric Design in Protein Engineering....
6 min read
Brief introduction of ADC (Antibody-drug conjugate) clinical pharmacology Brief introduction of ADC (Antibody-drug conjugate) clinical pharmacology. Antibody-drug conjugate (ADC)...
4 min read
Venclyxto+Gazyvaro for chemotherapy-free first-line treatment of CLL Venclyxto+Gazyvaro for chemotherapy-free first-line treatment of CLL. Leukemia bid farewell to chemotherapy:...
12 min read
Design strategy and production optimization of RNA targeted drugs Design strategy and production optimization of RNA targeted drugs. ...
11 min read
Immunomodulatory effects of targeted anticancer drugs Immunomodulatory effects of targeted anticancer drugs. In the past thirty years, a...
12 min read
How to choose the subtype of antibody for tumor immunotherapy? How to choose the subtype of antibody for tumor...
8 min read
Why is the approval of Biogen Alzheimer's antibody drug: Aducanumab highly controversial or even more harmful? Why is...
3 min read
New drugs for rare diseases! The U.S. FDA approved Ultomiris, a long-acting C5 complement inhibitor: treatment of paroxysmal nocturnal hemoglobinuria...
7 min read
What are ADC immunogenicity and characteristics of ADA immune response? What are ADC immunogenicity and characteristics of ADA immune response?...
4 min read
New medicine for cystic fibrosis (CF)! The US FDA approves the Vertex triple therapy Trikafta to expand the applicable population:...
7 min read
Biogen New Drug Aducanumab: Will targeting TREM2 be a new hope for AD? Biogen Aducanumab: Will targeting TREM2 be a...
3 min read
Targeted drug Truseltiq for cholangiocarcinoma effectively prolongs survival, orally administered Targeted drug Truseltiq for cholangiocarcinoma effectively prolongs survival. ...
5 min read
Exciting: Alzheimer's disease ushered in the first new drug in 18 years, FDA approved Aducanumab to market Exciting: Alzheimer's...
6 min read
The first drug to delay the progression of Alzheimer's disease was approved! First drug to delay the progression...
4 min read
The NK feeder cells of mIL-21 drive the strong expansion and metabolic activation of NK cells NK feeder cells of...
3 min read
Antibody cocktail REGEN-COV Emergency Use Authorization (EUA) updated: low-dose 1200mg to treat COVID-19 patients! Antibody cocktail REGEN-COV Emergency...
